Juvenile idiopathic arthritis (JIA) is an umbrella term for arthritis of unknown origin, lasting
for> 6 weeks with onset before 16 years of age. JIA is the most common chronic …

In the past two decades, the treatment of juvenile idiopathic arthritis (JIA) has evolved
markedly, owing to the availability of a growing number of novel, potent and relatively safe …

Objective The optimal time to start biologics in polyarticular juvenile idiopathic arthritis (JIA)
remains uncertain. The Childhood Arthritis and Rheumatology Research Alliance (CARRA) …

Recent development of new medications has changed the juvenile idiopathic arthritis (JIA)
treatment goal to inactive disease. With numerous options, how does a clinician choose …

Abstract Juvenile Idiopathic Arthritis (JIA) is the most common chronic rheumatic disease in
childhood, and is associated with uveitis in up to 20–25% of cases. Typically, the uveitis is …

Abstract Background The Childhood Arthritis and Rheumatology Research Alliance
(CARRA) developed consensus treatment plans (CTPs) to compare treatment initiation …

Introduction Childhood uveitis is a sight-threatening condition, because if not properly
recognized and treated can lead to several ocular complications and blindness. It represents …

Pediatric hematology-oncology (PHO) is 1 of the oldest recognized pediatric subspecialities.
PHO physicians care for infants, children, adolescents, and young adults with all types of …

Objective Inflammatory arthritides exhibit hallmark patterns of affected and spared joints, but
in each individual, arthritis affects only a subset of all possible sites. The purpose of this …

Objective To determine the frequency of subclinical synovitis on musculoskeletal
ultrasonography (MSUS) in juvenile idiopathic arthritis (JIA) and correlate patient‐and …